Nedocromil sodium 2% ophthalmic solution (Tilavist^TM) A new topical treatment for ocular allergic inflammation

References

• Cairns H, Cox D, Gould K J, Ingall A H, Suschitzky J L. New antiallergic pyrano [3,2-g]quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma. J Med Chem 1985; 28: 1832–1842
   PubMed Web of Science ®Google Scholar
• Cairns H, Orr T SC. The development of a new agent for the treatment of inflammatory/allergic conditions. Int Archs Allergy Appl Immunol 1987; 82: 513–517
   PubMedGoogle Scholar
• Rainey D K. Nedocromil sodium (Tilade): a review of preclinical studies. Eur Respir J 1989; 2((s6))561s–565s
   PubMedGoogle Scholar
• Gonzales J P, Brogden R N. Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease. Drugs 1987; 34: 560–577
   PubMed Web of Science ®Google Scholar
• Neale M G, Brown K, Foulds R A, Lal S, Morris D A, Thomas D. The pharmacokinetics of nedocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease. Br J Clin Pharmacol 1987; 24: 493–501
   PubMed Web of Science ®Google Scholar
• Allansmith M R, Ross R N. Ocular allergy. Clin Allergy 1988; 18: 1–13
   PubMedGoogle Scholar
• Proud D, Sweet J, Stein P, Settipane R A, Kagey-Sobotka A, Friedlaender M H, Lichtenstein L M. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 1990; 85: 896–905
   PubMed Web of Science ®Google Scholar
• Moqbel R, Cromwell O, Walsh G M, Wardlaw A J, Kurlak L, Kay A B. The effects of nedocromil sodium (Tilade) on activation of human eosinophils, neutrophils and histamine release from mast cells. Allergy 1988; 43: 268–276
   PubMed Web of Science ®Google Scholar
• Thorel T, Joseph M, Tsicopoulos A, Tonnel A B, Capron A. Inhibition by nedocromil sodium of IgE-mediated activation of human mononuclear phagocytes and platelets in allergy. Int Archs Allergy Appl Immunol 1988; 85: 232–237
   PubMedGoogle Scholar
• Bruijnzeel P LB, Warringa R AJ, Kok P TM. Inhibition of platelet activating factor- and zymosan activated serum induced chemotaxis of human neutrophils by nedocromil sodium, BN52021 and sodium cromoglycate. Br J Pharmacol 1989; 97: 1251–1257
   PubMed Web of Science ®Google Scholar
• Marquette C H, Joseph M, Tonnel A B, Vorng H, Lassalle P, Tsicopoulos A, Capron A. The abnormal in vitro response to aspirin of platelets from aspirin-sensitive asthmatics is inhibited after inhalation of nedocromil sodium but not of sodium cromoglycate. Br J Clin Pharmacol 1990; 29: 525–531
   PubMed Web of Science ®Google Scholar
• Eady R P. The pharmacology of nedocromil sodium-a review. Actual Chim Ther 1987; 14: 55–61
   Google Scholar
• Riley P A, Mather M E, Keogh R W, Eady R P. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat. Int Archs Allergy Appl Immunol 1987; 82: 108–110
   PubMedGoogle Scholar
• Wells E, Jackson C G, Harper S T, Mann J, Eady R P. Characterization of primate bronchoalveolar mast cells II. Inhibition of histamine, LTC4 and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. J Immunol 1986; 137: 3941–3945
   PubMed Web of Science ®Google Scholar
• Pearce F L, Al-Laith M, Bosman L, et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations. Drugs 1989; 37((sl))37–43
   PubMed Web of Science ®Google Scholar
• Abraham W M, Sielczak M W, Wanner A, et al. Cellular markers of inflammation in the airways of allergic sheep with and without allergen-induced late responses. Am Rev Respir Dis 1988; 138: 1565–1571
   PubMedGoogle Scholar
• Schellenberg R R, Ishida K, Thomson R J. Nedocromil sodium inhibits airway hyperresponsiveness and eosinophilic infiltration induced by repeated antigen challenge in guinea-pigs. Br J Pharmacol 1991; 103: 1842–1846
   PubMed Web of Science ®Google Scholar
• Richards R, Phillips G D, Holgate S T. Nedocromil sodium is more potent than sodium cromoglycate against AMP induced bronchoconstriction in atopic asthmatic subjects. Clin Exp Allergy 1989; 19: 285–291
   PubMed Web of Science ®Google Scholar
• Dixon C MS, Ind P W. Inhaled sodium metabisulphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Pharmacol 1990; 30: 371–376
   Web of Science ®Google Scholar
• Stockwell A, Easty D. Double blind group comparative trial of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis. Invest Ophthalmol Vis Sci 1988; 29: 229
   Google Scholar
• Hirsch S R, Melamed J, Schwartz R H. Efficacy of nedocromil sodium 2% ophthalmic solution in the treatment of ragweed seasonal allergic conjunctivitis. J Allergy Clin Immunol 1988; 81: 173
   Web of Science ®Google Scholar
• Leino M, Carison C, Jaanio E, Koivunen T, Lavikkala H, Riihela K, Takalo E. A double-blind group comparative study of 2% nedocromil sodium eye drops in the treatment of seasonal allergic conjunctivitis. Ann Allergy 1990; 64: 398–402
   PubMedGoogle Scholar
• Blumenthal M, Casale T, Dockhorn R, Jarmoszuk I, Kaiser H, Smith R, Zeitz H. A multicenter double-blind group comparative study of the efficacy and safety of b.i.d. nedocromil sodium 2% ophthalmic solution in the treatment of ragweed seasonal allergic conjunctivitis. Am J Ophthalmol 1992; 113: 56–63
   PubMed Web of Science ®Google Scholar
• Miglior M, Scullica L, Secchi A, et al. Nedocromil sodium and astemizole, alone or combined, in the treatment of seasonal allergic conjunctivitis. Acta Ophthalmol 1993, in press
   Web of Science ®Google Scholar
• Leino M, Ennevaara K, Latvala A-L, Nordgren P, Posti A-M, Suves R, Takalo E. Double-blind group comparative study of 2% nedocromil sodium eye drops with 2% sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy 1992; 22: 929–932
   PubMed Web of Science ®Google Scholar
• Bonini S t, Barney N P, Schiavone M, Centofanti M, Berruto A, Bonini S e, Allansmith M R. Effectiveness of nedocromil sodium 2% eye drops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis. Eye 1992; 6: 648–652
   PubMed Web of Science ®Google Scholar